Context Therapeutics Inc. (CNTX)
undefined
undefined%
At close: undefined
1.33
-3.97%
After-hours Dec 13, 2024, 07:27 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 12.04K 9.27K - - -
Gross Profit -12.04K -9.27K - - -
Operating Income -25.07M -15.38M -10.53M -2.57M -5.38M
Interest Income 1.16M 547.27K 64.24 661.22 1.10K
Pretax Income -23.96M -14.84M -10.46M 6.64M -6.38M
Net Income -23.96M -14.29M -7.43M 6.64M -7.48M
Selling & General & Admin 7.29M 7.79M 3.63M 930.67K 2.97M
Research & Development 17.78M 7.09M 3.81M 1.64M 2.41M
Other Expenses 0.00 -2.00K 123.87K 9.88M 93.36K
Operating Expenses 25.07M 14.88M 7.44M 2.57M 5.38M
Interest Expense - 547.27K 64.24K 661.22K 1.10M
Selling & Marketing Expenses - - - - -
Cost & Expenses 25.07M 14.88M 7.44M 2.57M 5.38M
Income Tax - -545.26K -3.02M 661.22K 1.10M
Shares Outstanding (Basic) 15.97M 15.97M 15.97M 10.96M 10.96M
Shares Outstanding (Diluted) 15.97M 15.97M 15.97M 10.96M 10.96M
EPS (Basic) -1.5 -0.9 -0.47 0.61 -0.68
EPS (Diluted) -1.5 -0.9 -0.47 0.61 -0.68
EBITDA -25.06M -14.83M -10.53M - -
Depreciation & Amortization 12.04K 9.27K -3.09M 2.57M 5.38M